BBB pathology and pharmacology

The capillaries of the central nervous system forming the blood-brain barrier (BBB) regulate the brain microenvironment by restricting ionic, fluid and cell movements between the blood and the brain, by supplying brain cells with essential nutrients, and by protecting them from toxic molecules in the blood. Prof. Ferenc Joó, the first head of the Laboratory of Molecular Neurobiology and his co-workers created the first in vitro model of the BBB by the successful isolation of viable brain microvessels more than 35 years ago. Experiments on isolated brain microvessels provided important data on cerebral endothelial receptors, transporters, and signaling mechanisms. Continuing their work we have developed new BBB models by the co-culture of brain endothelial cells, glial cells and pericytes to study cell–cell interaction in the neurovascular unit, modulation of BBB permeability in physiological, pathological, and pharmacological conditions and to screen drug candidate molecules to predict brain penetration.








The protection of brain endothelial cells and the improvement of BBB functions in pathological conditions, the exploration of new approaches for drug transport/targeting to brain may have a therapeutical potential in the treatment of central nervous system diseases.